Does APREMILAST Cause Squamous cell carcinoma? 45 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Squamous cell carcinoma have been filed in association with APREMILAST (Otezla). This represents 0.0% of all adverse event reports for APREMILAST.
45
Reports of Squamous cell carcinoma with APREMILAST
0.0%
of all APREMILAST reports
1
Deaths
7
Hospitalizations
How Dangerous Is Squamous cell carcinoma From APREMILAST?
Of the 45 reports, 1 (2.2%) resulted in death, 7 (15.6%) required hospitalization, and 2 (4.4%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which APREMILAST Alternatives Have Lower Squamous cell carcinoma Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA